Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 1995

Sauter E R, Ridge J A, Litwin S, Langer C J

Abstract excerpt

Relatively little is known about p53 changes in far-advanced head and neck cancer for several reasons: (a) most patients respond well to initial treatment; (b) most institutions do not encounter large numbers of these patients; (c) recurrent or metastatic disease is often within body cavities ina...

Topics

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Female
Genes, p53
Head and Neck Neoplasms
Humans
Male
Mutation
Neoplasm Proteins
Prognosis
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 9815938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9815938-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics